Omeros Corp (NASDAQ:OMER)

14.03
Delayed Data
As of Apr 20
 -0.90 / -6.03%
Today’s Change
8.36
Today|||52-Week Range
27.09
-27.79%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$546.6M

Company Description

Omeros Corp. operates as a biopharmaceutical company specializes in discovery, development, and commercializes of both small-molecule and protein therapeutics for large -market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Contact Information

Omeros Corp.
The Omeros Building
Seattle Washington 98119
P:(206) 676-5000
Investor Relations:

Employees

Shareholders

Individual stakeholders7.01%
Other institutional34.96%
Mutual fund holders14.39%

Top Executives

Gregory A. DemopulosChairman, President & Chief Executive Officer
Michael A. JacobsenCFO, Treasurer, Chief Accounting Officer & VP
George A. GaitanarisChief Scientific Officer & VP-Science
J. Steven WhitakerChief Medical Officer & VP-Clinical Development
Kenneth M. FergusonChief Development Officer & Vice President